• Home
• Services
• One-Stop Microfluidic Solutions
• Organ-On-A-Chip Solution
• CBLMF™ 3D Tissue and Organ-On-A-Chip Model Development Services
• Tumor-Organ-On-A-Chip Model

Are you currently facing challenges in accurately modeling the complex cochlear environment, experiencing limitations with traditional animal models, or struggling with the high costs and time associated with inner ear drug development? Creative Biolabs' Tumor-on-a-chip Model Development Service helps you overcome these hurdles and accelerate your research through cutting-edge microfluidic technology and advanced cell culture techniques. We provide you with a physiologically relevant and highly controllable in vitro platform for studying cochlear function, disease mechanisms, and therapeutic interventions.

Contact our team to get an inquiry now!

Background

Tumor diseases became the world's second-leading cause of mortality in 2018. Global data from 2020 indicates roughly 19.3 million incident cancer cases and 10 million deaths linked to oncological conditions. Extensive scientific investigations target the molecular drivers of tumor initiation, metastatic dissemination, and pathological progression. Traditional monolayer cell culture systems have prevailed in drug development research for generations, favored for low technical complexity and economic viability. These systems involve adherent cellular monolayers on non-compliant substrates, propagating within simplified nutrient conditions. While enabling basic cellular proliferation analyses, 2D configurations distort native cell morphology, cytoskeletal organization, and paracrine communication networks. Crucially, they lack the three-dimensional scaffolding essential for emulating histological complexity. This structural deficit prevents physiologically relevant extracellular matrix (ECM) engagement—known to regulate neoplastic behavior via mechanotransduction and biochemical signaling—rendering 2D platforms inadequate for replicating in vivo tumor microenvironments.

Fig 1. The tumor microenvironment (TME).^1,4

Tumor-on-a-chip

The tumor-on-chip platform demonstrates distinctive capabilities in vascular network development. This system integrates three-dimensional neoplastic constructs with precision-engineered fluidic architectures, maintaining continuous nutrient delivery while modeling biological transport phenomena including vascular dynamics and molecular exchange. Fabrication typically initiates with scaffold-based methodologies for 3D tumor analogs, subsequently integrated into microfluidic platforms. Advanced manufacturing approaches like soft lithographic patterning and additive bioprinting enables histologically relevant assemblies of malignant, stromal, and endothelial components. Core techniques encompass spheroid aggregation, bioink deposition, and scaffold templating.

Fig 2. Tumor-on-a-chip platforms.^2,4

Microfluidic technology, emerging from the interdisciplinary convergence of cellular biology and microfabrication, maintains cellular viability within micron-scale microenvironments through picoliter-scale fluidic manipulation. Fluid dynamics are precisely orchestrated through engineered micro-conduits interfaced with microfluidic systems, enabling spatiotemporal regulation of tumor microenvironmental parameters to quantify cellular kinetics and live-cell transport phenomena. Device microarchitectures incorporate cell-laden hydrogels or perfusible lumen networks, emulating biomechanical forces and architectural constraints characteristic of living tissues. Diverse chip iterations now facilitate mechanistic investigations into neoplastic phenotypes, metastatic behavior, vascular morphogenesis, and therapeutic compound evaluation.

Fig 3. Vascularization in microfluidic devices.^3,4

Innovative microphysiological tumor platforms enable comprehensive investigation of oncological processes including proliferation, vascularization, metastatic behavior, and therapeutic response. By integrating precision biofabrication methods—such as photolithography, soft lithography, and 3D bioprinting—with microfluidic controls and tissue engineering principles, these systems recapitulate critical tumor microenvironment features: molecular gradient systems, dynamic cell-ECM interactions, and multicellular architectures incorporating malignant and stromal populations.

Table 1. Summary of the different types of tumor-on-a-chip.^2,4

Applications

Creative Biolabs' Tumor-On-A-Chip Model Development Service can be applied to a wide range of cancer research applications, including:

• Drug discovery and development: Evaluating the efficacy and toxicity of novel anticancer drugs in a physiologically relevant context.
• Personalized medicine: Developing patient-specific tumor models to predict drug response and optimize treatment strategies.
• Cancer biology research: Studying the mechanisms of tumor progression, metastasis, and drug resistance.
• Immunotherapy research: Investigating the interactions between cancer cells and immune cells in the TME.
• Development of novel cancer therapies: Identifying new therapeutic targets and strategies for cancer treatment.

Experience the Creative Biolabs Advantage - Get a Quote Today

Why Choose Us?

Creative Biolabs is a trusted partner for researchers and biopharmaceutical companies seeking advanced in vitro models for cancer research. Our Tumor-On-A-Chip Model Development Service offers several key advantages:

• Customized Solutions: Creative Biolabs works closely with you to develop tailored Tumor-On-A-Chip models that precisely match your specific research needs and experimental objectives.
• Advanced Technology: Creative Biolabs utilizes state-of-the-art microfluidic technology and cutting-edge 3D cell culture techniques to create highly realistic and physiologically relevant tumor models.
• Expert Team: Our team comprises experienced biologists, engineers, and data scientists with extensive expertise in microfluidics, cell biology, and cancer research. We provide expert guidance and support throughout the entire project lifecycle.
• Reproducible Results: Creative Biolabs' rigorous quality control processes ensure the reproducibility and reliability of our Tumor-On-A-Chip models, leading to more robust and meaningful data.
• Accelerated Research: By providing more predictive and physiologically relevant models, Creative Biolabs' service can help you accelerate your research timelines, reduce costs, and improve the efficiency of your drug discovery efforts.

FAQs

Recommended Products

For researchers facing challenges in initiating microfluidic cellular investigations de novo, Creative Biolabs' engineered cell-culture systems deliver integrated solutions that streamline workflow bottlenecks.

Our chips offer the freedom to choose the cell seeding channels and perfusion conditions, enabling various cell culture modes.

For more information about Creative Biolabs products and services, please contact us.

References

1. Ahn, Jungho, et al. "Tumor microenvironment on a chip: the progress and future perspective." Bioengineering 4.3 (2017): 64.
2. Liu, Xingxing, et al. "Tumor-on-a-chip: from bioinspired design to biomedical application." Microsystems & Nanoengineering 7.1 (2021): 50.
3. Wang, Ruixin, et al. "Tumor-on-a-chip: Perfusable vascular incorporation brings new approach to tumor metastasis research and drug development." Frontiers in Bioengineering and Biotechnology 10 (2022): 1057913.
4. Distributed under Open Access license CC BY 4.0, without modification.

For Research Use Only. Not For Clinical Use.